chr5-40955459-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000587.4(C7):​c.1166G>C​(p.Ser389Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.58 in 1,612,408 control chromosomes in the GnomAD database, including 274,957 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 21765 hom., cov: 32)
Exomes 𝑓: 0.59 ( 253192 hom. )

Consequence

C7
NM_000587.4 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.42

Publications

41 publications found
Variant links:
Genes affected
C7 (HGNC:1346): (complement C7) This gene encodes a serum glycoprotein that forms a membrane attack complex together with complement components C5b, C6, C8, and C9 as part of the terminal complement pathway of the innate immune system. The protein encoded by this gene contains a cholesterol-dependent cytolysin/membrane attack complex/perforin-like (CDC/MACPF) domain and belongs to a large family of structurally related molecules that form pores involved in host immunity and bacterial pathogenesis. This protein initiates membrane attack complex formation by binding the C5b-C6 subcomplex and inserts into the phospholipid bilayer, serving as a membrane anchor. Mutations in this gene are associated with a rare disorder called C7 deficiency. [provided by RefSeq, Nov 2016]
C7 Gene-Disease associations (from GenCC):
  • complement component 7 deficiency
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=3.067753E-5).
BP6
Variant 5-40955459-G-C is Benign according to our data. Variant chr5-40955459-G-C is described in ClinVar as Benign. ClinVar VariationId is 1169275.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.591 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C7NM_000587.4 linkc.1166G>C p.Ser389Thr missense_variant Exon 10 of 18 ENST00000313164.10 NP_000578.2 P10643Q05CI3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C7ENST00000313164.10 linkc.1166G>C p.Ser389Thr missense_variant Exon 10 of 18 1 NM_000587.4 ENSP00000322061.9 P10643

Frequencies

GnomAD3 genomes
AF:
0.523
AC:
79420
AN:
151914
Hom.:
21760
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.333
Gnomad AMI
AF:
0.505
Gnomad AMR
AF:
0.568
Gnomad ASJ
AF:
0.659
Gnomad EAS
AF:
0.538
Gnomad SAS
AF:
0.540
Gnomad FIN
AF:
0.659
Gnomad MID
AF:
0.639
Gnomad NFE
AF:
0.596
Gnomad OTH
AF:
0.551
GnomAD2 exomes
AF:
0.575
AC:
142760
AN:
248154
AF XY:
0.579
show subpopulations
Gnomad AFR exome
AF:
0.320
Gnomad AMR exome
AF:
0.584
Gnomad ASJ exome
AF:
0.666
Gnomad EAS exome
AF:
0.569
Gnomad FIN exome
AF:
0.640
Gnomad NFE exome
AF:
0.598
Gnomad OTH exome
AF:
0.591
GnomAD4 exome
AF:
0.586
AC:
856107
AN:
1460376
Hom.:
253192
Cov.:
40
AF XY:
0.586
AC XY:
425484
AN XY:
726488
show subpopulations
African (AFR)
AF:
0.322
AC:
10774
AN:
33430
American (AMR)
AF:
0.580
AC:
25850
AN:
44538
Ashkenazi Jewish (ASJ)
AF:
0.658
AC:
17174
AN:
26114
East Asian (EAS)
AF:
0.505
AC:
20031
AN:
39638
South Asian (SAS)
AF:
0.536
AC:
46110
AN:
86008
European-Finnish (FIN)
AF:
0.645
AC:
34427
AN:
53384
Middle Eastern (MID)
AF:
0.614
AC:
3537
AN:
5764
European-Non Finnish (NFE)
AF:
0.597
AC:
663262
AN:
1111166
Other (OTH)
AF:
0.579
AC:
34942
AN:
60334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
17869
35738
53606
71475
89344
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18014
36028
54042
72056
90070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.523
AC:
79457
AN:
152032
Hom.:
21765
Cov.:
32
AF XY:
0.527
AC XY:
39193
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.333
AC:
13815
AN:
41458
American (AMR)
AF:
0.569
AC:
8681
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.659
AC:
2289
AN:
3472
East Asian (EAS)
AF:
0.539
AC:
2784
AN:
5166
South Asian (SAS)
AF:
0.537
AC:
2586
AN:
4814
European-Finnish (FIN)
AF:
0.659
AC:
6964
AN:
10564
Middle Eastern (MID)
AF:
0.636
AC:
187
AN:
294
European-Non Finnish (NFE)
AF:
0.596
AC:
40523
AN:
67978
Other (OTH)
AF:
0.554
AC:
1168
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1890
3780
5671
7561
9451
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
696
1392
2088
2784
3480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.590
Hom.:
20094
Bravo
AF:
0.507
TwinsUK
AF:
0.581
AC:
2156
ALSPAC
AF:
0.587
AC:
2263
ESP6500AA
AF:
0.345
AC:
1310
ESP6500EA
AF:
0.613
AC:
5060
ExAC
AF:
0.570
AC:
68817
Asia WGS
AF:
0.511
AC:
1777
AN:
3476
EpiCase
AF:
0.601
EpiControl
AF:
0.603

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 24, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Benign
0.037
T
Eigen
Benign
0.043
Eigen_PC
Benign
-0.10
FATHMM_MKL
Benign
0.62
D
LIST_S2
Benign
0.44
T
MetaRNN
Benign
0.000031
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Uncertain
2.8
M
PhyloP100
1.4
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.17
Sift
Benign
0.067
T
Sift4G
Uncertain
0.013
D
Polyphen
0.94
P
Vest4
0.19
MPC
0.061
ClinPred
0.037
T
GERP RS
1.4
Varity_R
0.28
gMVP
0.60
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1063499; hg19: chr5-40955561; COSMIC: COSV57475104; API